Cargando…
Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model
Triple-negative breast cancer (TNBC) is a highly aggressive phenotype that is resistant to standard therapy. Thus, the development of alternative therapeutic strategies for TNBC is essential. The purpose of our in vitro study was to evaluate the impact of p53 gene silencing in conjunction with the a...
Autores principales: | Braicu, Cornelia, Pileczki, Valentina, Pop, Laura, Petric, Roxana Cojocneanu, Chira, Sergiu, Pointiere, Eve, Achimas-Cadariu, Patriciu, Berindan-Neagoe, Ioana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4388814/ https://www.ncbi.nlm.nih.gov/pubmed/25849487 http://dx.doi.org/10.1371/journal.pone.0120936 |
Ejemplares similares
-
p53 siRNA - a therapeutic tool with significant implication in the modulation of apoptosis and angiogenic pathways
por: BRAICU, OVIDIU, et al.
Publicado: (2015) -
Clinical and pathological implications of miRNA in bladder cancer
por: Braicu, Cornelia, et al.
Publicado: (2015) -
Normalization of gene expression measurement of tissue samples obtained by transurethral resection of bladder tumors
por: Pop, Laura A, et al.
Publicado: (2016) -
Premature senescence activation in DLD-1 colorectal cancer cells through adjuvant therapy to induce a miRNA profile modulating cellular death
por: Chira, Sergiu, et al.
Publicado: (2018) -
Comprehensive Analysis of the Expression of Key Genes Related to Hippo Signaling and Their Prognosis Impact in Ovarian Cancer
por: Kubelac, Paul, et al.
Publicado: (2021)